MEI Pharma Balance Sheet - Quarterly (NASDAQ:MEIP)

Add to My Stocks
$4.55 $0.06 (1.3%) MEIP stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company like MEI Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. As in our MEI Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing MEI Pharma revenue MEI Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The MEI Pharma balance sheet for 2018 Q4 shows cash on hand of $13.31M. The company has a debt to equity ratio of 0.

View and download MEI Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jul - Jun2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Cash13.31M6.19M7.33M6.95M8.45M11.64M15.05M13.78M10.83M14.29M
Marketable Securities89.43M30M35.1M40.06M45.1M45.11M40.1M45.11M35.08M35.11M
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.59M---1.75M2.75M2.66M1.74M-1.1M
Total Current Assets
104.33M37.05M43.21M47.66M55.32M59.51M57.82M60.64M46.74M50.5M
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
104.66M37.39M43.56M48.03M55.7M59.89M58.21M61.04M47.16M50.93M
Notes Payable----------
Accounts Payable3.64M1.25M1.08M-----1.07M-
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses3.45M2.38M3.23M2.76M3.28M3.71M2.93M2.42M4.43M3.55M
Income Taxes Payable----------
Other Current Liabilities-----1.03M-14.04M--
Total Current Liabilities
7.89M4.48M5.2M4.46M4.86M4.98M3.32M17.22M5.51M4.02M
Mortgages----------
Deferred Taxes/Income-------1.49M--
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities46.31M---------
Total Liabilities
54.2M4.48M5.2M4.46M4.86M4.98M3.32M18.71M5.51M4.02M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus264.86M228.05M227.55M226.68M225.16M224.89M224.27M223.6M218.65M218.13M
Retained Earnings-214.4M-195.14M-189.19M-183.11M-174.33M-169.98M-169.38M-181.27M-177M-171.23M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity50.46M32.91M38.35M43.56M50.83M54.9M54.89M42.33M41.65M46.9M
Total Liabilities & Shareholders Equity104.66M37.39M43.56M48.03M55.7M59.89M58.21M61.04M47.16M50.93M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at MEI Pharma historical stock prices and the current MEI Pharma stock price can tell you how the stock price has moved, whereas the MEI Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the MEI Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. MEI Pharma had total assets of $104.66M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. MEIP stock had total liabilities of $54.2M for the quarter 2018 Q4.

MEI Pharma Balance Sheet - Key Ratios

Current ratio
13.22
Debt to equity ratio
0
Asset turnover ratio
0.03
Receivables turnover
0
Price to book ratio
5.63